The primary objective of our centre is to translate recent huge advances in the basic understanding of the pathogenesis of coeliac disease to the clinic – to improve disease diagnostics, to implement novel treatments and to identify new therapeutic targets for this common disease.
The secondary objective is to become a clinical research site at the international forefront which will provide optimal patient care and which will be a unique training site for basic scientists and clinicians.
News
-
Ludvig M Sollid wins University of Oslo's research prize for 2022 Sep. 29, 2022 8:07 PMOn September 2, J CoDiRC centre leader Ludvig M. Sollid received the research prize from the University of Oslo. This prize acknowledges his longstanding national and international leading contribution to research in celiac disease and human mucosal immunology. Congratulations!
-
Machine intelligence to tackle the complexity of adaptive immune receptors Nov. 18, 2021 3:58 PMThis November, Milena Pavlović and Lonneke Scheffer, PhD students in the group of prof. Geir Kjetil Sandve at the Department of Informatics (UiO) published their computational framework Immune ML in Nature Machine Intelligence. ImmuneML is a freely available tool that allows researchers to tackle complex computational questions related to studies of adaptive immune receptor repertoires. This tool will be an important resource for all studies that link B cell receptor and T cell receptor sequence data to antigen recognition and disease. For celiac disease, this represents one step closer towards the goal of detecting genes of gluten specific T cells directly in blood.
